Medicine Beyond the Numbers: Extrapolating Today’s Trends Forward By admin June 21, 2024 0 Comment on Beyond the Numbers: Extrapolating Today’s Trends Forward
Medicine What the Leaders of the Most Effective Teams Know By admin June 20, 2024 0 Comment on What the Leaders of the Most Effective Teams Know
Medicine FDA Approves AbbVie’s Skyrizi for the Treatment of Adults with Moderate to Severely Active Ulcerative Colitis By admin June 20, 2024 0 Comment on FDA Approves AbbVie’s Skyrizi for the Treatment of Adults with Moderate to Severely Active Ulcerative Colitis
Medicine Utilizing Biomarkers to Develop First-in-Class Antibody Drug Conjugates to Treat Advanced Solid Tumors By admin June 19, 2024 0 Comment on Utilizing Biomarkers to Develop First-in-Class Antibody Drug Conjugates to Treat Advanced Solid Tumors
Medicine FDA Approves AstraZeneca’s Imfinzi for Mismatch Repair Deficient Primary Advanced or Recurrent Endometrial Cancer By admin June 18, 2024June 18, 2024 0 Comment on FDA Approves AstraZeneca’s Imfinzi for Mismatch Repair Deficient Primary Advanced or Recurrent Endometrial Cancer
Medicine FDA Approves Amgen’s Blincyto to Treat CD19-Positive Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia By admin June 17, 2024 0 Comment on FDA Approves Amgen’s Blincyto to Treat CD19-Positive Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia
Medicine Pharmaceutical Executive: June 2024 Issue (PDF) By admin June 16, 2024 0 Comment on Pharmaceutical Executive: June 2024 Issue (PDF)
Medicine Pharmaceutical Executive: June 2024 Issue (PDF) By admin June 16, 2024 0 Comment on Pharmaceutical Executive: June 2024 Issue (PDF)
Medicine Imbruvica Demonstrates Long-Term Efficacy, Safety in First-Line Treatment of Chronic Lymphocytic Leukemia By admin June 15, 2024June 15, 2024 0 Comment on Imbruvica Demonstrates Long-Term Efficacy, Safety in First-Line Treatment of Chronic Lymphocytic Leukemia